Nico Lachmann, PhD1,2,3*, Christine Happle, MD4*, Takuji Suzuki, MD5*, Miriam Hetzel1,2*, Kevin A. Link, PhD6, Adele Mucci1,2*, Paritha Arumugam, PhD7*, Jens Bankstahl, PhD8*, Dagmar Dilloo, MD9, Punam Malik, MD6*, Carolyn Lutzko, PhD6*, Axel Schambach, MD, PhD2*, Bruce Colston Trapnell, MD5*, Gesine Hansen, MD4* and Thomas Moritz, MD1,2*
1Reprogramming and Gene Therapy Group, REBIRTH Cluster of Excellence, Hannover Medical School, Hannover, Germany, Hannover, Germany
2Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
3JRG Translational Hematology of Congenital Diseases, REBIRTH Cluster of Excellence, Hannover Medical School, Hannover, Germany
4Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
5Division of Pulmonary Biology, Children’s Hospital Medical Center, Cincinnati, OH
6Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Translational Pulmonary Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
8Institute for Preclinical Molecular Imaging, Hannover Medical School, Hannover, Germany, Hannover, Germany
9Department of Pediatric Hematology and Oncology, Center for Child and Adolescent Medicine, Rheinische Friedrich-Wilhelms University, Bonn, Germany, Dusseldorf, Germany